Ropivacaine Hydrochloride (Sagent Pharmaceuticals)


Welcome to the PulseAid listing for the Ropivacaine Hydrochloride drug offered from Sagent Pharmaceuticals. This Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view the details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.

LABELER NAME / MANUFACTURER: Sagent Pharmaceuticals
NON-PROPRIETARY NAME: ropivacaine hydrochloride
SUBSTANCE NAME: ROPIVACAINE HYDROCHLORIDE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Amide Local Anesthetic [EPC],Amides [Chemical/Ingredient],Local Anesthesia [PE]
ROUTE: EPIDURAL; PERINEURAL
DOSAGE FORM: INJECTION, SOLUTION
MARKETING CATEGORY NAME: ANDA
START MARKETING DATE: 2014-09-23
END MARKETING DATE: 0000-00-00


Ropivacaine Hydrochloride HUMAN PRESCRIPTION DRUG Details:

Item DescriptionRopivacaine Hydrochloride from Sagent Pharmaceuticals
LABELER NAME: Sagent Pharmaceuticals
DEA SCHEDULE:
ACTIVE STRENGTH: 7.5(mg/mL)
START MARKETING DATE: 2014-09-23
END MARKETING DATE: 0000-00-00
PRODUCT ID: 25021-654_3ea57cba-ac27-4721-880d-79949a271bf6
PRODUCT NDC: 25021-654
APPLICATION NUMBER: ANDA090318

Other ROPIVACAINE HYDROCHLORIDE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Akorn, Inc.Ropivacaine Hydrochloride
AuroMedics Pharma LLCRopivacaine Hydrochloride
Fresenius Kabi USA, LLCNaropin
General Injectables & Vaccines, IncNAROPIN
Hospira, Inc.Ropivacaine Hydrochloride
Sagent PharmaceuticalsRopivacaine Hydrochloride
Sandoz IncRopivacaine Hydrochloride